Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry

Bente Glintborg, Tina Kringelbach, Estrid Høgdall, Inge Juul Sørensen, Dorte Vendelbo Jensen, Anne Gitte Loft, Oliver Hendricks, Inger Marie Jensen Hansen, Nils Bolstad, David J. Warren, Johanna Gehin, Guro Goll, Kathrine Grøn, Grith Eng, Christian Enevold, Claus Henrik Nielsen, Julia S. Johansen, Merete L. Hetland

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberOP10
JournalScandinavian Journal of Rheumatology
Volume45
Issue numberSupplement 128
Pages (from-to)6
Number of pages1
ISSN0300-9742
Publication statusPublished - 2016
Event36th Scandinavian Congress of Rheumatology - Harpa , Reykjavík, Iceland
Duration: 1. Sep 20163. Sep 2016

Conference

Conference36th Scandinavian Congress of Rheumatology
LocationHarpa
Country/TerritoryIceland
CityReykjavík
Period01/09/201603/09/2016

Cite this